Page last updated: 2024-12-05

4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-terpineol : A terpineol that is 1-menthene carrying a hydroxy substituent at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11230
CHEMBL ID507795
CHEBI ID78884
SCHEMBL ID22344
MeSH IDM0528469

Synonyms (98)

Synonym
unii-l65mv77zg6
hsdb 8264
terpinenolu-4
l65mv77zg6 ,
4-06-00-00250 (beilstein handbook reference)
einecs 209-235-5
1-p-menthen-4-ol
4-carvomenthenol (natural)
terpinenolu-4 [czech]
para-menth-1-en-4-ol
terpinenol-4
4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol
(+-)-p-menth-1-en-4-ol
ccris 9067
fema no. 2248
1-menthene-4-ol
4-methyl-1-isopropyl-3-cyclohexen-1-ol
nsc 147749
einecs 248-910-9
brn 1906603
1-methyl-4-isopropyl-1-cyclohexen-4-ol
(1)-1-(isopropyl)-4-methylcyclohex-3-en-1-ol
1-para-menthen-4-ol
terpinen-4-ol
nsc-147749
4-carvomenthenol
1-terpinen-4-ol
4-terpineol
562-74-3
3-cyclohexen-1-ol, 4-methyl-1-(1-methylethyl)-
nsc147749
terpinene-4-ol
p-menth-1-en-4-ol
terpene-4-ol
4-carvomenthenol, natural, >=95%, fg
4-carvomenthenol, >=95%, fcc, fg
4-methyl-1-propan-2-ylcyclohex-3-en-1-ol
terpineol-4
C17073
chebi:78884 ,
CHEMBL507795
(+/-)-terpinen-4-ol
(+/-)-1-isopropyl-4-methyl-3-cyclohexen-1-ol
M0319
(+/-)-p-menth-1-en-4-ol
T1993
(-)-1-isopropyl-4-methyl-3-cyclohexen-1-ol
(-)-p-menth-1-en-4-ol
(+/-)-4-hydroxy-4-isopropyl-1-methyl-1-cyclohexene
(-)-4-hydroxy-4-isopropyl-1-methyl-1-cyclohexene
cas-562-74-3
tox21_301785
4-methyl-1-(propan-2-yl)cyclohex-3-en-1-ol
dtxcid2024824
dtxsid4044824 ,
NCGC00256250-01
rac terpinen-4-ol
dl-4-terpineol
(+/-)-4-terpineol
FT-0619472
FT-0604437
FT-0604405
AKOS015903412
S6118
4-carvomenthenol [fhfi]
4-terpineol, (+/-)-
terpinen-4-ol,(+/-)-
1-(isopropyl)-4-methylcyclohex-3-en-1-ol
4-terpineol [inci]
terpinen-4-ol [fcc]
methyl-1-(1-methylethyl)-3-cyclohexen-1-ol
SCHEMBL22344
terpin-4-en-1-ol
alpha-terpinen-4-ol
1-isopropyl-4-methylcyclohex-3-en-1-ol
1-isopropyl-4-methyl-cyclohex-3-en-1-ol
l-4-terpineol
l-4-terpineneol
1-isopropyl-4-methyl-3-cyclohexen-1-ol, (r)-
l-terpinen-4-ol
mfcd00001562
terpinen 4-ol, primary pharmaceutical reference standard
1-isopropyl-4-methyl-3-cyclohexen-1-ol
origanol
alpha -terpinen-4-ol
fema 2248
SY012857
terpinine-4-ol
A918559
DB12816
1-isopropyl-4-methylcyclohex-3-enol
Q416114
terpinen 4-ol
AC1341
HY-W017316
CS-W018032
AS-56462
SB44714

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The dermal pharmacokinetic study of terpinen-4-ol was performed under non-occlusive conditions."( Dermal pharmacokinetics of Terpinen-4-ol following topical administration of Zingiber cassumunar (plai) oil.
Chooluck, K; Derendorf, H; Sathirakul, K; Singh, RP, 2012
)
0.38

Bioavailability

ExcerptReferenceRelevance
"The objectives of the current study are (i) to maximize the ocular bioavailability of dorzolamide hydrochloride (DZD) through; (a) enhancement of the DZD corneal transport using various concentrations of selected natural terpene-4-ol enhancers, (b) increasing the contact time of the drug with the absorbing tissues of the eye using selected carbopol-934 (C-934) as mucoadhesive to reduce the extensive pre-corneal loss of the installed dose due to the physiologically normal fast tear-washout, and (ii) to assess the in vivo intraocular pressure (IOP) lowering effects of the gel test formulations using normotensive New Zealand albino rabbits."( Influence of various concentrations of terpene-4-ol enhancer and carbopol-934 mucoadhesive upon the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide ophthalmic formulations using albino rabbits.
Abdel-Naim, AB; Afouna, MI; Al-Marzoqi, A; Khedr, A, 2010
)
0.36

Dosage Studied

ExcerptRelevanceReference
" In static Franz diffusion cells permeation experiments with heat separated human epidermis were carried out using infinite dosing conditions and compared to liberation experiments."( In vitro studies on release and human skin permeation of Australian tea tree oil (TTO) from topical formulations.
Kostka, KH; Landvatter, U; Reichling, J; Schaefer, UF; Wagner, H, 2006
)
0.33
" In this study we applied TTO in its pure form and as a 20% solution in ethanol in vitro to human epidermal membranes from three different donors, mounted in horizontal Franz-type diffusion cells, using normal 'in use' dosing conditions (10 mg/cm2)."( Human skin penetration of the major components of Australian tea tree oil applied in its pure form and as a 20% solution in vitro.
Cross, SE; Roberts, MS; Russell, M; Southwell, I, 2008
)
0.35
"This work aimed to evaluate the effect induced by excipients conventionally used for topical dosage forms, namely isopropyl myristate (IPM) or oleic acid (OA) or polyethylene glycol 400 (PEG400) or Transcutol (TR), on the human skin permeability of terpinen-4-ol (T4OL) contained in the pure Tea tree oil."( The effects of excipients for topical preparations on the human skin permeability of terpinen-4-ol contained in Tea tree oil: infrared spectroscopic investigations.
Casiraghi, A; Cilurzo, F; Gambaro, V; Minghetti, P; Montanari, L; Selmin, F,
)
0.13
" Following topical application of the oil, terpinen-4-ol rapidly distributed into the dermis and demonstrated linear pharmacokinetics with no changes in the dose-normalized area under the concentration-time curves across the investigated dosage range."( Dermal pharmacokinetics of Terpinen-4-ol following topical administration of Zingiber cassumunar (plai) oil.
Chooluck, K; Derendorf, H; Sathirakul, K; Singh, RP, 2012
)
0.38
" Finally, a dose-response correlation was observed between Waldhemia glabra essential oil concentration and viability of human breast adenocarcinoma cells MDA-MB-231 and MCF-7."( Screening of the chemical composition and bioactivity of Waldheimia glabra (Decne.) Regel essential oil.
Catalano, E; Dallavalle, S; Giorgi, A; Iriti, M; Manzo, A; Musso, L; Panseri, S; Scarì, G, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (5 Product(s))

Product Categories

Product CategoryProducts
Beauty & Personal Care5

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Jason Purifying Tea Tree Shampoo -- 12 fl ozJasonBeauty & Personal Carecitric acid, 4-terpineol, ascorbic acid, benzyl alcohol, citric acid, panthenol, triethyl citrate, glycerin2024-11-29 10:47:42
Tree to Tub Balancing Tea Tree Face Wash for Oily Skin -- 4 fl ozTree to TubBeauty & Personal Carecaprylyl glycol, 4 - terpineol, cocamidopropyl betaine, decyl glucoside2024-11-29 10:47:42
Tree to Tub Clarifying Shampoo for Oily Hair & Sensitive Scalp -- 8.5 fl ozTree to TubBeauty & Personal Carecaprylyl glycol, citric acid, 4-terpineol, citric acid, cocamidopropyl betaine, decyl glucoside, glyceryl caprylate, glyceryl, sodium benzoate2024-11-29 10:47:42
Tree to Tub Dry Scalp Spray Instant Calm -- 3.4 fl ozTree to TubBeauty & Personal Carebutylene glycol, 4-terpineol, allantoin, lactic acid, menthol, piroctone olamine, propylene glycol, sugar2024-11-29 10:47:42
Tree to Tub Peppermint & Tea Tree Shampoo and Conditioner for Oily Hair Set of 2 -- 8.5 fl oz Each (17 fl oz)Tree to TubBeauty & Personal Carecaprylyl glycol, isopropyl alcohol, citric acid, 4-terpineol, cetearyl alcohol, palm, citric acid, cocamidopropyl betaine, decyl glucoside, glyceryl stearate, glycerin, glyceryl caprylate, sodium lauroyl sarcosinate, sodium benzoate2024-11-29 10:47:42

Roles (8)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
antiparasitic agentA substance used to treat or prevent parasitic infections.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
volatile oil componentAny plant metabolite that is found naturally as a component of a volatile oil.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
terpineolA family of monoterpenols that have a p-menthane skeleton containing one double bond and bearing a single hydroxy substituent.
tertiary alcoholA tertiary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has three other carbon atoms attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency24.33650.000657.913322,387.1992AID1259377
estrogen nuclear receptor alphaHomo sapiens (human)Potency61.38770.000229.305416,493.5996AID743069; AID743079
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency24.54120.023723.228263.5986AID743223
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (38)

Assay IDTitleYearJournalArticle
AID334999Antimicrobial activity against Pityrosporum ovale ATCC 14521 by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID334993Antimicrobial activity against Streptococcus mutans ATCC 25175 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID338297Acaricidal activity against Psoroptes cuniculi at 1% dilution in physiological saline after 48 hrs by direct contact assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID1081539Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 48 hr assessed as reduction in larval motility2010Journal of agricultural and food chemistry, Jul-14, Volume: 58, Issue:13
Phytochemistry and nematicidal activity of the essential oils from 8 Greek Lamiaceae aromatic plants and 13 terpene components.
AID1612094Myorelaxant activity in California White rabbit duodenum assessed as relaxation of high-potassium-induced contraction2018European journal of medicinal chemistry, Sep-05, Volume: 157Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus.
AID338302Acaricidal activity against Psoroptes cuniculi at 1 uL after 24 hrs by inhalation assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID334995Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID338299Acaricidal activity against Psoroptes cuniculi at 0.125% dilution in physiological saline after 48 hrs by direct contact assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID332912Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method1994Journal of natural products, Jan, Volume: 57, Issue:1
Naturally occurring antiacne agents.
AID334990Antimicrobial activity against Brevibacterium ammoniagenes ATCC 6872 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID334994Antimicrobial activity against Escherichia coli ATCC 9637 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID338301Acaricidal activity against Psoroptes cuniculi at 3 uL after 24 hrs by inhalation assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID1612093Cytotoxicity against human HL60 cells assessed as reduction in cell viability after 24 hrs by MTT assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus.
AID1612099Antifungal activity against Histoplasma capsulatum filamentous phase after 7 days by broth microdilution method2018European journal of medicinal chemistry, Sep-05, Volume: 157Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus.
AID338300Acaricidal activity against Psoroptes cuniculi at 6 uL after 24 hrs by inhalation assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID334998Antimicrobial activity against Candida utilis ATCC 9226 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID334992Antimicrobial activity against Staphylococcus aureus ATCC 12598 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID334997Antimicrobial activity against Saccharomyces cerevisiae ATCC 7754 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1612098Antifungal activity against Coccidioides posadasii filamentous phase after 48 hrs by broth microdilution method2018European journal of medicinal chemistry, Sep-05, Volume: 157Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus.
AID555351Effect on growth in Staphylococcus aureus MN8 at 0.65 mM after 24 hrs (Rvb = 100%)2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
AID1081538Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 24 hr assessed as reduction in larval motility2010Journal of agricultural and food chemistry, Jul-14, Volume: 58, Issue:13
Phytochemistry and nematicidal activity of the essential oils from 8 Greek Lamiaceae aromatic plants and 13 terpene components.
AID555382Induction of toxin TSST-1 production in Staphylococcus aureus MN8 at 6.50 mM after 24 hrs relative to control2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
AID555350Effect on growth in Staphylococcus aureus MN8 at 6.50 mM after 24 hrs (Rvb = 100%)2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
AID334991Antimicrobial activity against Propionibacterium acnes ATCC 11827 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID334996Antimicrobial activity against Enterobacter aerogenes ATCC 13048 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1090745Antifungal activity against Aspergillus flavus assessed as mycelial growth at 20 uL after 4 to 12 days by agar disk diffusion method relative to untreated control2007Journal of agricultural and food chemistry, Aug-22, Volume: 55, Issue:17
Characterization of the volatile constituents in the essential oil of Pistacia lentiscus L. from different origins and its antifungal and antioxidant activity.
AID555383Induction of toxin TSST-1 production in Staphylococcus aureus MN8 at 0.65 mM after 24 hrs relative to control2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
AID335000Antimicrobial activity against Penicillium chrysogenum ATCC 10106 after 5 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID334989Antimicrobial activity against Bacillus subtilis ATCC 9372 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID338298Acaricidal activity against Psoroptes cuniculi at 0.25% dilution in physiological saline after 48 hrs by direct contact assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID1081540Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 96 hr assessed as reduction in larval motility2010Journal of agricultural and food chemistry, Jul-14, Volume: 58, Issue:13
Phytochemistry and nematicidal activity of the essential oils from 8 Greek Lamiaceae aromatic plants and 13 terpene components.
AID1612100Antifungal activity against Histoplasma capsulatum yeast phase after 4 days by broth microdilution method2018European journal of medicinal chemistry, Sep-05, Volume: 157Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus.
AID360503Antioxidant activity assessed as DPPH radical scavenging activity1995Journal of natural products, Nov, Volume: 58, Issue:11
Santolindiacetylene, a polyacetylene derivative isolated from the essential oil of Santolina canescens.
AID624608Specific activity of expressed human recombinant UGT1A42000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1090744Antifungal activity against Aspergillus flavus assessed as mycelial growth at 60 uL after 4 to 12 days by agar disk diffusion method relative to untreated control2007Journal of agricultural and food chemistry, Aug-22, Volume: 55, Issue:17
Characterization of the volatile constituents in the essential oil of Pistacia lentiscus L. from different origins and its antifungal and antioxidant activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (177)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.56)18.7374
1990's5 (2.82)18.2507
2000's45 (25.42)29.6817
2010's88 (49.72)24.3611
2020's38 (21.47)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.40 (24.57)
Research Supply Index5.25 (2.92)
Research Growth Index5.72 (4.65)
Search Engine Demand Index28.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (2.15%)5.53%
Reviews8 (4.30%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other174 (93.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]